{"id":396837,"date":"2025-03-15T14:00:00","date_gmt":"2025-03-15T13:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/e-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa\/"},"modified":"2025-03-15T14:09:07","modified_gmt":"2025-03-15T13:09:07","slug":"e-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/e-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa\/","title":{"rendered":"\u00c8 iniziato lo studio di fase 3 QuANTUM wild per i pazienti con AML FLT3-ITD-negativa"},"content":{"rendered":"\n<p><strong>La leucemia mieloide acuta (AML) \u00e8 una delle forme pi\u00f9 comuni di leucemia negli adulti. Ad oggi, non esistono inibitori di FLT3 approvati per i pazienti con AML FLT3-ITD-negativa, sebbene l&#8217;attivazione sostenuta del recettore FLT3 possa contribuire alla progressione della malattia in questa popolazione di pazienti. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fe-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La leucemia mieloide acuta (AML) \u00e8 una delle forme pi\u00f9 comuni di leucemia negli adulti. Ad oggi, non esistono inibitori di FLT3 approvati per i pazienti con AML FLT3-ITD-negativa, sebbene&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fe-iniziato-lo-studio-di-fase-3-quantum-wild-per-i-pazienti-con-aml-flt3-itd-negativa%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396839,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Leucemia mieloide acuta  ","footnotes":""},"category":[11361,11519,11537,11376,11550,11515],"tags":[81783,81884],"powerkit_post_featured":[],"class_list":["post-396837","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ematologia","category-formazione-continua","category-mercato-e-medicina","category-oncologia-it","category-rx-it","category-studi","tag-leucemia-mieloide-acuta","tag-quizartinib-it","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-11 11:52:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":396831,"slug":"iniciado-o-ensaio-quantum-wild-de-fase-3-em-doentes-com-lma-flt3-itd-negativa","post_title":"Iniciado o ensaio QuANTUM wild de fase 3 em doentes com LMA FLT3-ITD-negativa","href":"https:\/\/medizinonline.com\/pt-pt\/iniciado-o-ensaio-quantum-wild-de-fase-3-em-doentes-com-lma-flt3-itd-negativa\/"},"es_ES":{"locale":"es_ES","id":396824,"slug":"se-inicia-el-ensayo-quantum-wild-de-fase-3-para-pacientes-con-lma-flt3-itd-negativa","post_title":"Se inicia el ensayo QuANTUM wild de fase 3 para pacientes con LMA FLT3-ITD negativa","href":"https:\/\/medizinonline.com\/es\/se-inicia-el-ensayo-quantum-wild-de-fase-3-para-pacientes-con-lma-flt3-itd-negativa\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=396837"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396837\/revisions"}],"predecessor-version":[{"id":397224,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396837\/revisions\/397224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/396839"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=396837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=396837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=396837"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=396837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}